United Therapeutics Corporation (UTHR)
Debt-to-assets ratio
| Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-term debt | US$ in thousands | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Total assets | US$ in thousands | 7,364,000 | 7,123,100 | 6,723,200 | 6,495,200 | 7,167,000 | 7,023,600 | 6,681,300 | 6,346,000 | 6,044,500 | 5,781,600 | 5,543,300 | 5,359,800 | 5,169,100 | 5,048,900 | 4,844,900 | 4,641,000 | 4,615,000 | 4,411,200 | 4,219,400 | 4,025,900 |
| Debt-to-assets ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
December 31, 2024 calculation
Debt-to-assets ratio = Long-term debt ÷ Total assets
= $—K ÷ $7,364,000K
= 0.00
The data shows that United Therapeutics Corporation has maintained a consistently low debt-to-assets ratio of 0.00 over the period from March 31, 2020, to December 31, 2024. This indicates that the company has not relied heavily on debt to finance its operations and investments, as the ratio suggests that there is no debt recorded against the company's total assets during this period. A debt-to-assets ratio of 0.00 typically reflects a strong financial position, as it signifies that the company's assets are primarily funded by equity rather than debt. This can be seen as a positive indicator of financial stability and lower financial risk for United Therapeutics Corporation, as it demonstrates prudent financial management and a strong balance sheet.
Peer comparison
Dec 31, 2024